Syspath Holdings Pty Ltd

Status: Strike-off action in progress
Australian Company Number: 099908504
Australian Business Number: 11099908504
Registration date: 2002/03/14
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Syspath Holdings Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2002-03-14 and was issued with the 099908504 ACN. Its Australian Business Number is 11099908504. Since 2014-09-21, the company is headquartered in NSW, post code 2067. The previous headquarters were located in NSW 2067 (from 2014-01-12 to 2014-09-21), NSW 2067 (from 2002-04-04 to 2014-01-12). The company has also used 1 business name, namely Sydney Skin Pathology from 2002-04-04 to 2013-12-03. The above data comes from the ABN database which was updated on 2017-07-27.

Details for ABN 11099908504

Type: Australian Private Company

ABN Status

Status From To
Active 2002/04/04 current

Main Name

Name From To
Syspath Holdings Pty Ltd 2002/04/04 current

Business Names

Name From To
Sydney Skin Pathology 2002/04/04 2013/12/03

Main Location

Location From To
NSW 2067 2014/09/21 current
NSW 2067 2014/01/12 2014/09/21
NSW 2067 2002/04/04 2014/01/12

Advertisements

Find company

NSW 2067 Location

2019 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2019 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2019, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.